Effect of Perfusion Temperature on the Inflammatory Response During Pediatric Cardiac Surgery

Annals of Thoracic Surgery

Volumn 85, Issue 2, 2008, Pages 611-617

  Eggum, Rune ^a,b   Ueland, Thor ^a   Mollnes, Tom E ^a   Videm, Vibeke ^c   Aukrust, Pål ^a   Fiane, Arnt E ^a   Lindberg, Harald L ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Sykehuset Buskerud HF   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 8; MYELOPEROXIDASE;

ADULT; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DISEASE SEVERITY; EXTRACORPOREAL CIRCULATION; FEMALE; GENERAL ANESTHESIA; HEART PERFUSION; HEART SURGERY; HUMAN; HYPOTHERMIA; INFLAMMATION; LEUKOCYTE COUNT; MALE; OPEN HEART SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; TEMPERATURE SENSITIVITY;

CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; HYPOTHERMIA, INDUCED; INFANT; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MULTIVARIATE ANALYSIS; PERFUSION; PROBABILITY; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; TEMPERATURE; TIME FACTORS; TREATMENT OUTCOME;

EID: 38349124461     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.10.062     Document Type: Article

References (31)

1. Hirai S. Systemic inflammatory response syndrome after cardiac surgery under cardiopulmonary bypass. Ann Thorac Cardiovasc Surg 9 (2003) 365-370
2. Holmes IV J.H., Connolly N.C., Paull D.L., et al. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflamm Res 51 (2002) 579-586
3. Madhok A.B., Ojamaa K., Haridas V., Parnell V.A., Pahwa S., and Chowdhury D. Cytokine response in children undergoing surgery for congenital heart disease. Pediatr Cardiol 27 (2006) 408-413
4. Allen M.L., Hoschtitzky J.A., Peters M.J., et al. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit Care Med 34 (2006) 2658-2665
5. Edmunds L.H. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 66 5 suppl (1998) S12-S16 discussion S25-8
6. Gessler P., Pretre R., Hohl V., Rousson V., Fischer J., and Dahinden C. CXC-chemokine stimulation of neutrophils correlates with plasma levels of myeloperoxidase and lactoferrin and contributes to clinical outcome after pediatric cardiac surgery. Shock 22 (2004) 513-520
7. Jensen E., Bengtsson A., Berggren H., Ekroth R., and Andreasson S. Clinical variables and pro-inflammatory activation in paediatric heart surgery. Scand Cardiovasc J 35 (2001) 201-206
8. Ashraf S.S., Tian Y., Zacharrias S., Cowan D., Martin P., and Watterson K. Effects of cardiopulmonary bypass on neonatal and paediatric inflammatory profiles. Eur J Cardiothorac Surg 12 (1997) 862-868
9. Duval E.L., Kavelaars A., Veenhuizen L., van Vught A.J., van de Wal H.J., and Heijnen C.J. Pro- and anti-inflammatory cytokine patterns during and after cardiac surgery in young children. Eur J Pediatr 158 (1999) 387-393
10. Carta M.G., Serra P., Ghiani A., et al. Chemokines and pro-inflammatory cytokines in Down's syndrome: an early marker for Alzheimer-type dementia?. Psychother Psychosom 71 (2002) 233-236
11. Bel A., Elleuch N., Florens E., and Menaschè P. Temperature and inflammatory response on cardiopulmonary bypass. Cardiovasc Eng 6 (2001) 25-28
12. Honore P.M., Jacquet L.M., Beale R.J., et al. Effects of normothermia versus hypothermia on extravascular lung water and serum cytokines during cardiopulmonary bypass: a randomized, controlled trial. Crit Care Med 29 (2001) 1903-1909
13. Mollnes T.E., Garred P., and Bergseth G. Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation. Clin Exp Immunol 73 (1998) 484-488
14. Lindholm L., Bengtsson A., Hansdottir V., Lundqvist M., Rosengren L., and Jeppsson A. Regional oxygenation and systemic inflammatory response during cardiopulmonary bypass: influence of temperature and blood flow variations. J Cardiothorac Vasc Anesth 17 (2003) 182-187
15. Birdi I., Caputo M., Underwood M., Bryan A.J., and Angelini G.D. The effects of cardiopulmonary bypass temperature on inflammatory response following cardiopulmonary bypass. Eur J Cardiothorac Surg 16 (1999) 540-545
16. Lacour-Gayet F., Clarke D., Jacobs J., et al. The Aristotle score: a complexity-adjusted method to evaluate surgical results. Eur J Cardiothorac Surg 25 (2004) 911-924
17. Draaisma A.M., Hazekamp M.G., Anes N., et al. Phosphorylcholine coating of bypass systems used for young infants does not attenuate the inflammatory response. Ann Thorac Surg 81 (2006) 1455-1459
18. Mollnes T.E. Analysis of in vivo complement activation. In: Herzenberg L.A., Weir D.M., and Blackwell C. (Eds). Weir's Handbook of Experimental Immunology. 5th ed. (1997), Blackwell Science, Boston 1-78
19. Videm V. Heparin in clinical doses "primes" granulocytes to subsequent activation as measured by myeloperoxidase release. Scand J Immunol 43 (1996) 385-390
20. Van Beaumont W. Evaluation of hemoconcentration from hematocrit measurements. J Appl Physiol 32 (1972) 712-713
21. Alcaraz A.J., Manzano L., Sancho L., et al. Different proinflammatory cytokine serum pattern in neonate patients undergoing open heart surgery. Relevance of IL-8. J Clin Immunol 25 (2005) 238-245
22. Grossi E.A., Kallenbach K., Chau S., et al. Impact of heparin bonding on pediatric cardiopulmonary bypass: a prospective randomized study. Ann Thorac Surg 70 (2000) 191-196
23. Hickey E., Karamlou T., You X., et al. The use of a miniaturized circuit and bloodless prime to avoid cerebral no-reflow after neonatal cardiopulmonary bypass. Ann Thorac Surg 83 (2007) 895-901
24. van den Goor J., Nieuwland R., van den Brink A., et al. Reduced complement activation during cardiopulmonary bypass does not affect the postoperative acute phase response. Eur J Cardiothorac Surg 26 (2004) 926-931
25. Levy J.H., and Tanaka K.A. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 75 (2003) S715-S720
26. Tassani P., Barankay A., Haas F., et al. Cardiac surgery with deep hypothermic circulatory arrest produces less systemic inflammatory response than low-flow cardiopulmonary bypass in newborns. J Thorac Cardiovasc Surg 123 (2002) 648-654
27. Speziale G., Ferroni P., Ruvolo G., et al. Effect of normothermic versus hypothermic cardiopulmonary bypass on cytokine production and platelet function. J Cardiovasc Surg (Torino) 41 (2000) 819-827
28. Caputo M., Bays S., Rogers C.A., et al. Randomized comparison between normothermic and hypothermic cardiopulmonary bypass in pediatric open-heart surgery. Ann Thorac Surg 80 (2005) 982-988
29. Rot A., and von Andrian U.H. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22 (2004) 891-928
30. Gloire G., Legrand-Poels S., and Piette J. NF-κB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 72 (2006) 1493-1505
31. von Hundelshausen P., Petersen F., and Brandt E. Platelet-derived chemokines in vascular biology. Thromb Haemost 97 (2007) 704-713